Shanghai - Delayed Quote CNY
Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (603707.SS)
11.29
-0.09
(-0.79%)
At close: April 28 at 3:00:03 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
3,877,478.28
3,931,387.28
3,712,720.46
3,686,692.95
2,914,880.93
Cost of Revenue
2,248,175.91
2,028,720.81
1,767,997.71
1,596,122.16
1,196,265.06
Gross Profit
1,629,302.37
1,902,666.47
1,944,722.75
2,090,570.79
1,718,615.87
Operating Expense
773,621.55
939,584.25
912,050.45
848,997.76
742,397.29
Operating Income
855,680.82
963,082.22
1,032,672.30
1,241,573.03
976,218.59
Net Non Operating Interest Income Expense
-192,599.92
-54,682.21
-26,274.48
-82,102.68
-59,236.92
Pretax Income
-544,862.06
-294,758.51
1,185,369.26
1,203,753.75
914,631.85
Tax Provision
-121,861.63
-105,311.96
98,850.19
139,837.92
117,977.16
Net Income Common Stockholders
-422,968.19
-189,445.79
1,090,833.20
1,059,293.33
806,122.19
Basic EPS
-0.27
-0.12
0.67
0.67
0.66
Diluted EPS
-0.27
-0.12
0.67
0.67
0.66
Basic Average Shares
1,596,117.59
1,578,714.92
1,628,109.26
1,581,034.82
1,221,397.25
Diluted Average Shares
1,596,117.59
1,578,714.92
1,628,109.26
1,557,784.31
1,203,167.44
Total Operating Income as Reported
-524,488.64
-294,708.87
1,173,551.94
1,181,933.29
876,982.18
Rent Expense Supplemental
--
6,762.21
3,915.60
6,212.35
3,061.18
Total Expenses
3,021,797.46
2,968,305.06
2,680,048.16
2,445,119.92
1,938,662.34
Net Income from Continuing & Discontinued Operation
-422,968.19
-189,445.79
1,090,833.20
1,059,293.33
806,122.19
Normalized Income
545,318.93
611,647.53
1,101,574.73
1,064,276.70
851,258.64
Interest Income
11,815.28
27,983.43
33,393.12
12,041.82
1,483.44
Interest Expense
76,450.74
81,045.09
57,847
92,215.28
57,565.02
Net Interest Income
-192,599.92
-54,682.21
-26,274.48
-82,102.68
-59,236.92
EBIT
-468,411.31
-213,713.42
1,243,216.26
1,295,969.03
972,196.88
EBITDA
-468,411.31
-59,653.91
1,382,748.63
1,389,190.61
1,056,746
Reconciled Cost of Revenue
2,248,175.91
2,028,720.81
1,767,997.71
1,596,122.16
1,196,265.06
Reconciled Depreciation
--
154,059.51
139,532.37
93,221.58
84,549.13
Net Income from Continuing Operation Net Minority Interest
-422,968.19
-189,445.79
1,090,833.20
1,059,293.33
806,122.19
Total Unusual Items Excluding Goodwill
-1,247,239.66
-1,246,415.25
-11,718.78
-5,638.37
-51,820.75
Total Unusual Items
-1,247,239.66
-1,246,415.25
-11,718.78
-5,638.37
-51,820.75
Normalized EBITDA
778,828.34
1,186,761.34
1,394,467.41
1,394,828.98
1,108,566.75
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-278,952.55
-445,321.93
-977.25
-655
-6,684.29
12/31/2020 - 7/19/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade